Journals / Turkish Journal of Gastroenterology / 2004 / Cilt: 15 - Sayı: 3

Helikobakter pilori eradikasyonu ve fonksiyonel dispepsi

The effect of Helicobacter pylori eradication in patients with functional dyspepsia: Assessment of different diagnostic tests

Pages
159–163
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The finding of improved symptomscores after eradication suggests that Hp may play a role in functional dyspepsia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: Helicobacter pylori infection, is seen in more than 80% of adult population in Turkey.
📊
Key Findings & Data:The aims of this study were 1) to evaluate the importance of the diagnostic tests 2) to investigate the relationship between Hp infection and functional dyspepsia.
💡
Conclusion & Impact:The finding of improved symptomscores after eradication suggests that Hp may play a role in functional dyspepsia.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Dispepsi · Bizmut · Helicobacter pylori

Abstract

Background/Aims: Helicobacter pylori infection, is seen in more than 80% of adult population in Turkey. The aims of this study were 1) to evaluate the importance of the diagnostic tests 2) to investigate the relationship between Hp infection and functional dyspepsia. Methods: A total 75 patients with functional-dyspepsia were involved into the study. Hp infection was diagnosed by histopathological examination. CLO, cytology, culture, stool antigen and breath test. Symptom score using ROME II criteria was also evaluated to all patients. All patients were taken ranitidine-bismuth-citrate (400mg bid/day), clarithromycin (500mg bid/day) and amoxicillin (1000mg bid/day) for 14 days. All tests and symptom score analyses were re-applied at month 1and 6. Results: The eradication rate was 95.9%. The baseline specifity of breath test, CLO, cytology, culture and stool antigen were 87.3%, 95.4%, 95.4% 94.5% and 86.4%, respectively. The sensitivity of such tests at first month after stopping the treatment were 86.1%, 100%, 100%, 100%, 84.7%, respectively, and were 91.6%, 100%, 100%, 100%, 87.5%, respectively at six months after treatment. Symptom scores were 29.6±5.4, 15.8±4.7 and 17.9±5.3 at baseline, first month and six months after treatment, respectively (p<0.001). Conclusions: The success of eradication may be related to use of bismuth which prevents antibiotic resistance development. Stool antigen and breath tests are less effective than invasive diagnostic-tests. The finding of improved symptomscores after eradication suggests that Hp may play a role in functional dyspepsia.

Özet

Amaç: Türkiye’de erişkin populasyonda Helikobakter pilori infeksiyonu %80 den fazla oranda gözlenir. Bu çalışmanın amacı 1) tanısal testlerin önemini değerlendirmek 2) Hp infeksiyonu ile dispepsi ilişkisini araştırmaktır. Method: Fonksiyonel dispepsisi olan toplam 75 hasta çalışmaya dahil edildi. Hp tanısı histopatoloji ile kondu. Tüm hastalara aynı zamanda CLO, sitoloji, kültür, gaita antijeni ve nefes testi uygulandı. Tüm hastalara Roma II kriterlerine göre semptom skorlaması yapıldı. Hastalara ranitidin bizmut sitrat(400md bid9, klaritromisin(500mg bid) ve amoksisilin(1000mg bid) 14 gün boyunca uygulandı. Tüm testler ve semptom skoru 1 ve 6. aylarda tekrarlandı. Sonuçlar: Eradikasyon oranı %95.9 olarak bulundu. Başlangıç spesifiteleri nefes testi, CLO, sitoloji, kültür ve gaita antijeni için sırası ile %87.3, %95.4, %95.4, %94.5 ve %86.4 olarak bulundu. Aynı testlerin 1 ay sonraki sensitiviteleri 86.1%, 100%, 100%, 100%, 84.7% bulunurken, 6. ayda ise 91.6%, 100%, 100%, 100%, 87.5% şeklinde idi. Semptom skorları başlangıç, birinci ve altıncı aylarda sırası ile; 29.6±5.4, 15.8±4.7 ve 17.9±5.3 olarak bulundu(p<0.001). Yorum: Hp eradikasyonundaki başarı bizmutun ilaç rezistansı önleyici etkisi ile ilişkili olabilir. Histopatoloji, CLO, sitoloji ve kültür tanı koymakta etkilidir. CLO ve sitoloji sonuçları histopatoloji ile koreledir. Gaita antijeni ve nefes testi kabul edilebilir testker olmasına karşın diğer tanısal testlerden daha az etkili gibi görünmektedir. Semptom skorları tedavi ardından 6. ayda artmakla birlikte hala başlangıç değerlerinden anlamlı düşük seyretmektedir.

🔖

Cite This Article

ÇINAR, K., SOYKAN, İ., ÖZDEN, A. (2004). Helikobakter pilori eradikasyonu ve fonksiyonel dispepsi. Turkish Journal of Gastroenterology, Cilt: 15 - Sayı: 3, 159–163. https://ajindex.com/articles/410428

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Schlemper RJ, van der Werf SD, Biemond I, Lamers CB. Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease. Eur J Gastroenterol Hepatol 1996; 8: 33-9
  2. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review Gastroenterology. 1996; 110: 1244-52
  3. Morgner A, Lehn N, Andersen LP, et al. Helicobacter heilmanniiassociated primary gastric low-grade MALT lymphoma: complete remission after curing the infection. Gastroenterology 2000; 118: 821-8
  4. Dixon MF. Pathology of gastritis and peptic ulceration. In: Mobley HLT, Mendz GL, Hazell SL, eds. Helicobacter pylori: physiology and genetics. Washington, D. C.: ASM Press, 2001: 459-69
  5. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 1267-71
  6. Wotherspoon AC. Helicobacter pylori infection and gastric lymphoma. Br Med Bull 1998; 54: 79-85
  7. Bayerdorffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 1995; 345: 1591-4
  8. Malaty HM, Graham DY. Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut 1994; 35: 742-5
  9. Us D, Hascelik G. Seroprevalence of Helicobacter pylori infection in an Asymptomatic Turkish population. J Infect. 1998 Sep; 37(2): 148-50
  10. McColl K, Murray L, El-Omar E, et al. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998; 339: 1869-74
  11. Moayyedi P, Soo S, Deeks J, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2001; 1: CD002096
  12. Soil AH. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. JAMA 1996 Feb28; 275(8): 622-9
  13. Walsh JH, Peterson WL The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 1995 Oct 12; 333(15): 984-91
  14. Howden CW, Hunt RH. Guidelines for the management of Helicobacter pylori infection. Am J Gastroenterol 1998; 93: 2330-8
  15. Drumm B, Koletzko S, Oderda G. Helicobacter pylori infection in children: a consensus statement. J Pediatr Gastroenterol Nutr 2000; 30: 207-13
  16. Graham DY, Qureshi WA. Marker